Mohammad Ghasemi Hamed, the innovative co-founder of Odyssey Neuroscience, is at the forefront of cognitive enhancement technology. His startup is pioneering the integration of personalized Transcranial Electrical Stimulation (TES) with advanced AI algorithms. Holding a Ph.D. in Computer Science and boasting extensive expertise in statistical learning and data science, Mohammad has adeptly bridged the gap between academic research and entrepreneurial innovation. His groundbreaking work has culminated in the creation of the world's first AI-powered, individualized cognitive enhancement platform. Drawing from his background as an AI researcher, Mohammad infuses scientific precision with entrepreneurial vision in the realm of neurotechnology. His passionate pursuit of unlocking human cognitive potential offers unique insights at the convergence of neuroscience, artificial intelligence, and the optimization of human performance.

Dr. Horng-Dar Wang currently is a Professor and Chairman in the Department of Life Science and the Institute of Biotechnology and an adjunct Professor in both the Institute of Systems Neuroscience and Department of Life Science at National Tsing Hua University in Taiwan. Dr. Wang previously served as a Director at the Institute of Biotechnology from 2015 to 2021. Dr. Wang received his Ph.D. degree from Department of Molecular Pharmacology and Toxicology at the University of Southern California and did his post-doctoral scholar with Professor Seymour Benzer in the Biology Division at California Institute of Technology.His research interest focuses on the identification of novel genes to extend lifespan and promote healthspan in Drosophila and C. elegans, and applying the anti-aging gene effect on neurodegeneration and cancer research. Several longevity related genes have been identified not only able to extend lifespan but also prevent neurodegeneration and cancer proliferation.

Marco Carotenuto, MD, PhD, is a Full Professor of Child Neuropsychiatry with extensive expertise in sleep research and neurodevelopmental disorders. With a distinguished career spanning both clinical practice and academic research, Marco Carotenuto has made significant contributions to understanding the interplay between sleep and neurodevelopmental conditions in pediatric populations. A pivotal phase of Marco Carotenuto’s career was an extended tenure at the University of Oxford, UK, where they collaborated on groundbreaking studies in pediatric sleep medicine and neuropsychiatric disorders. This experience further refined their expertise in sleep architecture, cognitive development, and the neurobiological mechanisms underlying sleep disturbances in children with neurodevelopmental conditions. Throughout their career, he has led numerous funded research projects focusing on the impact of sleep disorders in children with conditions such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and mild traumatic brain injury (MTBI). His work has been instrumental in advancing the use of polysomnographic assessments in clinical and research settings, shedding light on the critical role of sleep in cognitive and emotional regulation. As a recognized leader in the field, he has authored numerous high-impact publications, served as a keynote speaker at international conferences, and contributed to the development of clinical guidelines for pediatric sleep disorders. Their ongoing research continues to bridge the gap between neuroscience and clinical practice, ultimately improving the diagnosis and treatment of sleep-related challenges in children with neuropsychiatric conditions.

Prof. Girijesh Prasad is Professor of Intelligent Systems in the School of Computing, Engineering and Intelligent Systems, Ulster University (UU), UK. He is Director of Northern Ireland Functional Brain Mapping (NIFBM) facility at UU’s Intelligent Systems Research Centre (ISRC), where he leads the Cognitive Neuroscience and Neurotechnology research team. He received a BTech in Electrical Engineering from Regional Engineering College (now National Institute of Technology) Calicut, India in 1987, an MTech in Computer Science and Technology from University of Roorkee (now Indian Institute of Technology Roorkee), India in 1992, and a PhD in Electrical Engineering from Queen's University of Belfast, UK in 1997. He is a Chartered Engineer, a Fellow of IET, a Fellow of Higher Education Academy, a Senior Member of IEEE, and a founder member of IEEE Systems, Man, and Cybernetics society’s Technical Committee on Brain-Machine Interface Systems. In 2017, he was awarded the Fellowship of International Academy of Physical Sciences (IAPS) India, and the Senior Distinguished Research Fellowship of Ulster University. Prof. Prasad joined Ulster University, as a Lecturer in 1999; he was promoted to Senior Lecturer in 2007, Reader in 2008, and Professor in 2011. Previously he worked in industry first as a Digital Systems Engineer and then as a Power Plant Engineer in India, and as a Research Fellow on an EPSRC/industry project at Queen’s University of Belfast, UK. His research interests are in intelligent systems, data engineering, brain modelling, brain-computer interface (BCI) & neuro-rehabilitation, and assistive technology. Under his supervision, an advanced rehabilitation protocol has been developed incorporating an active physical practice stage followed by a mental practice stage, using a neuro-rehab system consisting of a robotic hand exoskeleton and an EEG/EEG-EMG based BCI, which has been trialled on groups of chronic stroke patients in UK as well as India, resulting in transformative change in patients’ quality of life. He has published over 300 research papers in journals, edited books, and conference proceedings. He has supervised to completion 22 PhD students. His research has attracted 18 research grant awards amounting to over £10M funding from national and international agencies including Invest Northern Ireland, Department of Employment and Learning, Research Councils UK (RCUK), Leverhulme Trust, Royal Society, UK India Education and Research Initiative (UKIERI), UK Research and Innovation (UKRI) and Irish industry.

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hiredasaPostdoctoralScholarintheDepartmentofPharmacologyandPhysiologyatthe UniversityofSouthFloridainTampa,ontworesearchgrantsfundedbytheOfficeofNavalResearch(USNavy) and Divers’ Alert Network. He has written and lectured widelyworldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Dr. Mohita Shrivastava, Ph.D is an internationally trained Neuroscientist & Founder & CEO of the Cognitome Program, Cognitome LLC, Dubai. She holds a Ph.D. degree in the field of Neurosciences from Neurosciences Centre, AIIMS, New Delhi, India & her Ph.D research training from Kansas University Medical Centre, Kansas, USA. She holds two master’s degrees one in Biomedical Sciences from Dr, BR Ambedkar Centre for Biomedical Research, University of Delhi and other in Applied Clinical Psychology from Annamalai University. She also holds an Advanced PG Diploma in Applied Neuropsychology from the University of Bristol, United Kingdom. With more than a decade of experience in the industry, Dr. Shrivastava has been involved in Neuroscience and Neuropsychology teaching, research, therapeutics, projects, and outreach. She is the editorial board member for internationally acclaimed neuroscience journals & holds active membership of several esteemed international neuroscience societies dedicated to research and development in neurosciences. She has published peer-reviewed articles in international journals and columns on mental health in leading newspapers and magazines such as Khaleej Times (UAE’s National Daily), WKND Magazine and Passion Vista Global Magazine. Throughout her illustrious career, Dr. Shrivastava has received many awards and accolades and has been recently selected as Top Neuroscientist of the Year 2024 by the International Association of Top Professionals (IAOTP), NY, USA for her outstanding leadership, dedication, and commitment to the industry. She has also been awarded Global Mental Health Advocacy Leadership Award by Integrated Health & Wellness Council @10th IHW Summit in September 2024, Dubai. Dr. Shrivastava has been conferred with Outstanding Leadership Award in June 2023 and Visionaries Award in February 2024 in Dubai, UAE by Health 2.0 conferences. The Cognitome Program, a structured, neuroscientific, and holistic program, led by Dr. Shrivastava is a pioneering initiative effectively addresses issues related with cognition, cognitive impairment and age-related cognitive decline and offer therapeutic interventions and management for a wide range of brain and behavioral issues. By combining principles of neuroscience and neuropsychology, the program helps individuals tap into the brain's resources, by exploiting the concept of neuroplasticity and enabling personal and professional growth at any age or stage of life. The Cognitome Program, Cognitome LLC has been conferred with Outstanding Organization Award in Las Vegas, USA 2024 by Health 2.0 Conferences.

Dr. Tran is the Chairman and Chief Executive Officer of Biomed Industries, Inc., a leading biotechnology company dedicated to developing breakthrough treatments for neurodegenerative and metabolic diseases. Dr. Tran has over 30 years of experience in pharmaceutical research and development, specializing in treatments for neurodegenerative diseases, metabolic disorders, and infectious diseases. He began his career as a scientist at G.D. Searle (later acquired by Monsanto) and Pfizer before serving as Director of Research & Development at Controlled Release Technology, Inc. Dr. Tran served as the Chief Scientific Officer for Biomed Pharmaceutical, Inc, and NeuroActiva, Inc. which was acquired by Biomed Industries, Inc. A pioneer in Alzheimer’s disease research, Dr. Tran was the first to identify the role of neurogenesis in its treatment. He holds multiple U.S. and international patents covering drugs targeting Alzheimer's disease, major depressive disorder, stroke, Rett syndrome, obesity, and Metabolic dysfunction-associated steatohepatitis (MASH). Dr. Tran has also contributed to global health initiatives, collaborating with Nobel laureate Dr. Tu Youyou in the development of Artemether for malaria treatment. Artemether plus lumefantrine (AL) is now approved in the U.S. and 86 countries worldwide. Additionally, he is the inventor of the MICROS Infusion System, which has been approved for marketing in the U.S. Beyond his scientific contributions, Dr. Tran serves as the Committee Chair of the Alzheimer’s International Society and has played a key role in advancing Alzheimer’s research. He holds a B.Sc. (Honours) in Chemistry from the University of Otago and a Ph.D. in Medicinal Chemistry from the University of Wellington, New Zealand.

Marco Carotenuto, MD, PhD, is a Full Professor of Child Neuropsychiatry with extensive expertise in sleep research and neurodevelopmental disorders. With a distinguished career spanning both clinical practice and academic research, Marco Carotenuto has made significant contributions to understanding the interplay between sleep and neurodevelopmental conditions in pediatric populations. A pivotal phase of Marco Carotenuto’s career was an extended tenure at the University of Oxford, UK, where they collaborated on groundbreaking studies in pediatric sleep medicine and neuropsychiatric disorders. This experience further refined their expertise in sleep architecture, cognitive development, and the neurobiological mechanisms underlying sleep disturbances in children with neurodevelopmental conditions. Throughout their career, he has led numerous funded research projects focusing on the impact of sleep disorders in children with conditions such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and mild traumatic brain injury (MTBI). His work has been instrumental in advancing the use of polysomnographic assessments in clinical and research settings, shedding light on the critical role of sleep in cognitive and emotional regulation. As a recognized leader in the field, he has authored numerous high-impact publications, served as a keynote speaker at international conferences, and contributed to the development of clinical guidelines for pediatric sleep disorders. Their ongoing research continues to bridge the gap between neuroscience and clinical practice, ultimately improving the diagnosis and treatment of sleep-related challenges in children with neuropsychiatric conditions.

Agostinho Leite D’Almeida, a renowned Portuguese scholar and clinician with extensive academic and clinical experience in neuroscience, neuropsychology, psychotherapy, and sexology. He has completed postgraduate and doctoral studies across prestigious institutions in Portugal, the USA, UK, and Spain, and is currently working on his PhD in General Neurosciences at Universidad Camilo José Cela, Madrid. Dr. Almeida is Co-founder of MAIEUTICA and UMAIA/ISMAI, where he also served as Pro-President and Director of Graduate Studies. He has taught and practiced internationally and is a certified clinical psychologist, neuropsychologist, and diplomate in sexology. He currently serves as Editor-in-Chief of the Journal of Forensic Psychology and supervises professional training in clinical neuropsychology and psychotherapy.

Will be updated soon...

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hiredasaPostdoctoralScholarintheDepartmentofPharmacologyandPhysiologyatthe UniversityofSouthFloridainTampa,ontworesearchgrantsfundedbytheOfficeofNavalResearch(USNavy) and Divers’ Alert Network. He has written and lectured widelyworldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Dr Rachel Worthington is a HCPC Registered Forensic Psychologist, Chartered Psychologist, and a full member of the Division of Forensic Psychology, including holding Associate Fellow status. She is also a Chartered Scientist. She has worked for over 20 years in prisons and forensic psychiatric hospitals undertaking risk assessments and therapy for clients engaging in offending behaviour who presented with mental illness, personality disorder, complex PTSD, acquired brain injury and neurodevelopmental disorders including ADHD and Autism. She is trained in diagnostic assessment tools for these conditions and completed a MEd in Adult Autism, a PG Cert in ADHD,as well as Level 7 Sensory Integration Foundations and Neuroscience. She also set up the first Psychologically Informed Environment (PIE) for adults with autism and undertook research in relation to self-harm, harmful sexual behaviour and aggression for clients with autism. Dr Worthington more recently moved to Manchester Metropolitan University as a Senior Lecturer and has continued to work in private practice with clients. She is author of the ‘Brain Friendly Passport’ which is a tool designed to assist clients and practitioners identify support needs for clients with neurodiverse needs. This is currently being used in community NHS services, prisons and secure hospitals. She has authored several book chapters and research papers including challenging bias in the assessment and treatment for people with ADHD, neurodiversity and violent extremism, improving access to education for people with ADHD, Autism and Trauma and Autism and Moral Injury.

Prof. Girijesh Prasad is Professor of Intelligent Systems in the School of Computing, Engineering and Intelligent Systems, Ulster University (UU), UK. He is Director of Northern Ireland Functional Brain Mapping (NIFBM) facility at UU’s Intelligent Systems Research Centre (ISRC), where he leads the Cognitive Neuroscience and Neurotechnology research team. He received a BTech in Electrical Engineering from Regional Engineering College (now National Institute of Technology) Calicut, India in 1987, an MTech in Computer Science and Technology from University of Roorkee (now Indian Institute of Technology Roorkee), India in 1992, and a PhD in Electrical Engineering from Queen's University of Belfast, UK in 1997. He is a Chartered Engineer, a Fellow of IET, a Fellow of Higher Education Academy, a Senior Member of IEEE, and a founder member of IEEE Systems, Man, and Cybernetics society’s Technical Committee on Brain-Machine Interface Systems. In 2017, he was awarded the Fellowship of International Academy of Physical Sciences (IAPS) India, and the Senior Distinguished Research Fellowship of Ulster University. Prof. Prasad joined Ulster University, as a Lecturer in 1999; he was promoted to Senior Lecturer in 2007, Reader in 2008, and Professor in 2011. Previously he worked in industry first as a Digital Systems Engineer and then as a Power Plant Engineer in India, and as a Research Fellow on an EPSRC/industry project at Queen’s University of Belfast, UK. His research interests are in intelligent systems, data engineering, brain modelling, brain-computer interface (BCI) & neuro-rehabilitation, and assistive technology. Under his supervision, an advanced rehabilitation protocol has been developed incorporating an active physical practice stage followed by a mental practice stage, using a neuro-rehab system consisting of a robotic hand exoskeleton and an EEG/EEG-EMG based BCI, which has been trialled on groups of chronic stroke patients in UK as well as India, resulting in transformative change in patients’ quality of life. He has published over 300 research papers in journals, edited books, and conference proceedings. He has supervised to completion 22 PhD students. His research has attracted 18 research grant awards amounting to over £10M funding from national and international agencies including Invest Northern Ireland, Department of Employment and Learning, Research Councils UK (RCUK), Leverhulme Trust, Royal Society, UK India Education and Research Initiative (UKIERI), UK Research and Innovation (UKRI) and Irish industry.

Dr. Srdjan Ljubisavljevic is a Professor at the Department for Neurology in the University Clinical Center of Nis, Serbia, and holding a concurrent position at the Faculty of Medicine in Nis. His illustrious academic journey has taken him through esteemed institutions such as the faculties in Nis, Belgrade, Athens, as well as enriching experiences in London, Rome, Prague, and Leiden. With a fervent dedication to advancing knowledge in his field, Dr. Ljubisavljevic has emerged as a leader in research projects focusing on headaches and pain medicine. His contributions to the scientific community are evident in the numerous publications he has authored, which have found their place in prestigious international scientific journals. Beyond his scholarly pursuits, Dr. Ljubisavljevic is actively engaged as a member of both national and international societies, where he shares his expertise and collaborates with peers from around the globe. His outstanding contributions have been recognized with several awards, not only for his pioneering work in neurology and headaches but also for his overall scientific endeavors, marking him as a beacon of excellence in his field.

Dr. Mohita Shrivastava, Ph.D is an internationally trained Neuroscientist & Founder & CEO of the Cognitome Program, Cognitome LLC, Dubai. She holds a Ph.D. degree in the field of Neurosciences from Neurosciences Centre, AIIMS, New Delhi, India & her Ph.D research training from Kansas University Medical Centre, Kansas, USA. She holds two master’s degrees one in Biomedical Sciences from Dr, BR Ambedkar Centre for Biomedical Research, University of Delhi and other in Applied Clinical Psychology from Annamalai University. She also holds an Advanced PG Diploma in Applied Neuropsychology from the University of Bristol, United Kingdom. With more than a decade of experience in the industry, Dr. Shrivastava has been involved in Neuroscience and Neuropsychology teaching, research, therapeutics, projects, and outreach. She is the editorial board member for internationally acclaimed neuroscience journals & holds active membership of several esteemed international neuroscience societies dedicated to research and development in neurosciences. She has published peer-reviewed articles in international journals and columns on mental health in leading newspapers and magazines such as Khaleej Times (UAE’s National Daily), WKND Magazine and Passion Vista Global Magazine. Throughout her illustrious career, Dr. Shrivastava has received many awards and accolades and has been recently selected as Top Neuroscientist of the Year 2024 by the International Association of Top Professionals (IAOTP), NY, USA for her outstanding leadership, dedication, and commitment to the industry. She has also been awarded Global Mental Health Advocacy Leadership Award by Integrated Health & Wellness Council @10th IHW Summit in September 2024, Dubai. Dr. Shrivastava has been conferred with Outstanding Leadership Award in June 2023 and Visionaries Award in February 2024 in Dubai, UAE by Health 2.0 conferences. The Cognitome Program, a structured, neuroscientific, and holistic program, led by Dr. Shrivastava is a pioneering initiative effectively addresses issues related with cognition, cognitive impairment and age-related cognitive decline and offer therapeutic interventions and management for a wide range of brain and behavioral issues. By combining principles of neuroscience and neuropsychology, the program helps individuals tap into the brain's resources, by exploiting the concept of neuroplasticity and enabling personal and professional growth at any age or stage of life. The Cognitome Program, Cognitome LLC has been conferred with Outstanding Organization Award in Las Vegas, USA 2024 by Health 2.0 Conferences.

Will be updated soon...

Prof. (Dr.) Nidhi Agarwal is a distinguished academician and researcher with over 20 years of teaching and research experience. She serves as a Professor at the Faculty of Social Sciences, Arts and Humanities at Lincoln University College, Malaysia. In addition to her academic role, she is the Chairperson of the CTE UP chapter in India and the General Secretary of the Globus Educational and Research Association (GE&RA). Dr. Agarwal has made significant contributions to the field of education through her authorship of 32 books and chapters at both national and international levels. Her expertise spans Educational Psychology, Methods and Techniques for Teaching, and she has published over 54 research papers in various prestigious journals, including those indexed by Scopus, UGC, and other peer-reviewed publications. She is a prolific speaker, having presented her research at numerous national and international conferences. Her commitment to academic excellence is evident through her role as a Resource Person in UGC-sponsored online refresher courses for university and college professors, where she has also developed comprehensive E-Content. Dr. Agarwal is the Editor-in-Chief of two esteemed journals: Globus Journal of Progressive Education and Cosmos Journal of Arts and Higher Education. Her expertise and insights have made her a sought-after keynote speaker, with over 30 national and international conference invitations. Dr. Agarwal has successfully supervised more than 15 PhD research scholars to the completion of their degrees, with 10 more currently under her guidance. She is an active member of the Organisation for Women in Science for the Developing World (OWSD)-Paris, UNESCO, and AIATE. Additionally, she serves as an international reviewer for the International Conference of Informing Science and Informing Technology in the USA. Her dedication to fostering academic growth extends to organizing various national and international conferences, workshops, faculty development programs (FDPs), and seminars. She has received numerous accolades, including the best paper award at ISCA and AIATE conferences, and has been honored twice with the Women Empowerment Award for her social activism with NGOs and contributions to education. Dr. Agarwal is also an active member of Rotary, further demonstrating her commitment to community service and empowerment.